Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3723272011 | Irinotecan only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3723273018 | Product containing only irinotecan in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan only product in parenteral dose form | Has active ingredient | Irinotecan (substance) | true | Inferred relationship | Some | 1 | |
| Irinotecan only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Irinotecan only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Irinotecan only product in parenteral dose form | Is a | Product containing irinotecan in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Irinotecan only product in parenteral dose form | Is a | Product containing only irinotecan (medicinal product) | true | Inferred relationship | Some | ||
| Irinotecan only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan liposome only product in parenteral dose form | Is a | True | Irinotecan only product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion | Is a | False | Irinotecan only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | False | Irinotecan only product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection | Is a | True | Irinotecan only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR